経皮・経粘膜ドラッグデリバリーの世界市場 2020年

• 英文タイトル：Global Transdermal and Transmucosal Drug Delivery Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115297 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、経皮・経粘膜ドラッグデリバリーの世界市場を調査対象にし、経皮・経粘膜ドラッグデリバリーの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（経皮ドラッグデリバリー、経粘膜ドラッグデリバリー）、用途別分析（クリニック、病院、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：3M、Tesa Labtec、Corium International、Antares Pharma、Tapemark、Aveva Drug Delivery Systems、Pantec Biosolutions、DURECT ・企業別売上、市場シェア ・経皮・経粘膜ドラッグデリバリーの地域別市場分析 ・経皮・経粘膜ドラッグデリバリーの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・経皮・経粘膜ドラッグデリバリーのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・経皮・経粘膜ドラッグデリバリーのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・経皮・経粘膜ドラッグデリバリーの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・経皮・経粘膜ドラッグデリバリーの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・経皮・経粘膜ドラッグデリバリーの種類別市場規模2015-2020：経皮ドラッグデリバリー、経粘膜ドラッグデリバリー ・経皮・経粘膜ドラッグデリバリーの用途別市場規模2015-2020：クリニック、病院、その他 ・経皮・経粘膜ドラッグデリバリーの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Transdermal and Transmucosal Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Transdermal and Transmucosal Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Transdermal and Transmucosal Drug Delivery market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Transdermal and Transmucosal Drug Delivery market has been segmented into:
Transdermal Drug Delivery
Transmucosal Drug Delivery

By Application, Transdermal and Transmucosal Drug Delivery has been segmented into:
Clinics
Hospitals
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Transdermal and Transmucosal Drug Delivery market presented in the report. This section sheds light on the sales growth of different regional and country-level Transdermal and Transmucosal Drug Delivery markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Transdermal and Transmucosal Drug Delivery market.

The report offers in-depth assessment of the growth and other aspects of the Transdermal and Transmucosal Drug Delivery market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Transdermal and Transmucosal Drug Delivery Market Share Analysis
Transdermal and Transmucosal Drug Delivery competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Transdermal and Transmucosal Drug Delivery sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Transdermal and Transmucosal Drug Delivery sales, revenue and market share for each player covered in this report.

The major players covered in Transdermal and Transmucosal Drug Delivery are:
3M
Tesa Labtec
Corium International
Antares Pharma
Tapemark
Aveva Drug Delivery Systems
Pantec Biosolutions
DURECT

レポート目次

---

1 Transdermal and Transmucosal Drug Delivery Market Overview
1.1 Product Overview and Scope of Transdermal and Transmucosal Drug Delivery
1.2 Classification of Transdermal and Transmucosal Drug Delivery by Type
1.2.1 Global Transdermal and Transmucosal Drug Delivery Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Type in 2019
1.2.3 Transdermal Drug Delivery
1.2.4 Transmucosal Drug Delivery
1.3 Global Transdermal and Transmucosal Drug Delivery Market by Application
1.3.1 Overview: Global Transdermal and Transmucosal Drug Delivery Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Global Transdermal and Transmucosal Drug Delivery Market by Regions
1.4.1 Global Transdermal and Transmucosal Drug Delivery Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Transdermal and Transmucosal Drug Delivery (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Transdermal and Transmucosal Drug Delivery Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Transdermal and Transmucosal Drug Delivery Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Transdermal and Transmucosal Drug Delivery Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Transdermal and Transmucosal Drug Delivery Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Transdermal and Transmucosal Drug Delivery Status and Prospect (2015-2025)
2 Company Profiles
2.1 3M
2.1.1 3M Details
2.1.2 3M Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 3M SWOT Analysis
2.1.4 3M Product and Services
2.1.5 3M Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.2 Tesa Labtec
2.2.1 Tesa Labtec Details
2.2.2 Tesa Labtec Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Tesa Labtec SWOT Analysis
2.2.4 Tesa Labtec Product and Services
2.2.5 Tesa Labtec Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.3 Corium International
2.3.1 Corium International Details
2.3.2 Corium International Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Corium International SWOT Analysis
2.3.4 Corium International Product and Services
2.3.5 Corium International Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.4 Antares Pharma
2.4.1 Antares Pharma Details
2.4.2 Antares Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Antares Pharma SWOT Analysis
2.4.4 Antares Pharma Product and Services
2.4.5 Antares Pharma Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.5 Tapemark
2.5.1 Tapemark Details
2.5.2 Tapemark Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Tapemark SWOT Analysis
2.5.4 Tapemark Product and Services
2.5.5 Tapemark Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.6 Aveva Drug Delivery Systems
2.6.1 Aveva Drug Delivery Systems Details
2.6.2 Aveva Drug Delivery Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Aveva Drug Delivery Systems SWOT Analysis
2.6.4 Aveva Drug Delivery Systems Product and Services
2.6.5 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pantec Biosolutions
2.7.1 Pantec Biosolutions Details
2.7.2 Pantec Biosolutions Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pantec Biosolutions SWOT Analysis
2.7.4 Pantec Biosolutions Product and Services
2.7.5 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.8 DURECT
2.8.1 DURECT Details
2.8.2 DURECT Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 DURECT SWOT Analysis
2.8.4 DURECT Product and Services
2.8.5 DURECT Transdermal and Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Transdermal and Transmucosal Drug Delivery Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Transdermal and Transmucosal Drug Delivery Players Market Share
3.2.2 Top 10 Transdermal and Transmucosal Drug Delivery Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Transdermal and Transmucosal Drug Delivery Revenue and Market Share by Regions
4.2 North America Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
4.3 Europe Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
4.5 South America Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
5 North America Transdermal and Transmucosal Drug Delivery Revenue by Countries
5.1 North America Transdermal and Transmucosal Drug Delivery Revenue by Countries (2015-2020)
5.2 USA Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
5.3 Canada Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
5.4 Mexico Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
6 Europe Transdermal and Transmucosal Drug Delivery Revenue by Countries
6.1 Europe Transdermal and Transmucosal Drug Delivery Revenue by Countries (2015-2020)
6.2 Germany Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
6.3 UK Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
6.4 France Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
6.5 Russia Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
6.6 Italy Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Countries
7.1 Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue by Countries (2015-2020)
7.2 China Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
7.3 Japan Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
7.4 Korea Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
7.5 India Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
8 South America Transdermal and Transmucosal Drug Delivery Revenue by Countries
8.1 South America Transdermal and Transmucosal Drug Delivery Revenue by Countries (2015-2020)
8.2 Brazil Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
8.3 Argentina Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Transdermal and Transmucosal Drug Delivery by Countries
9.1 Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue by Countries (2015-2020)
9.2 Saudi Arabia Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
9.3 UAE Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
9.4 Egypt Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
9.5 South Africa Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Transdermal and Transmucosal Drug Delivery Revenue and Market Share by Type (2015-2020)
10.2 Global Transdermal and Transmucosal Drug Delivery Market Forecast by Type (2019-2024)
10.3 Transdermal Drug Delivery Revenue Growth Rate (2015-2025)
10.4 Transmucosal Drug Delivery Revenue Growth Rate (2015-2025)
11 Global Transdermal and Transmucosal Drug Delivery Market Segment by Application
11.1 Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Application (2015-2020)
11.2 Transdermal and Transmucosal Drug Delivery Market Forecast by Application (2019-2024)
11.3 Clinics Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Transdermal and Transmucosal Drug Delivery Market Size Forecast (2021-2025)
12.1 Global Transdermal and Transmucosal Drug Delivery Market Size Forecast (2021-2025)
12.2 Global Transdermal and Transmucosal Drug Delivery Market Forecast by Regions (2021-2025)
12.3 North America Transdermal and Transmucosal Drug Delivery Revenue Market Forecast (2021-2025)
12.4 Europe Transdermal and Transmucosal Drug Delivery Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue Market Forecast (2021-2025)
12.6 South America Transdermal and Transmucosal Drug Delivery Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Transdermal and Transmucosal Drug Delivery Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Transdermal and Transmucosal Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Transdermal and Transmucosal Drug Delivery Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Transdermal and Transmucosal Drug Delivery Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. 3M Corporate Information, Location and Competitors
Table 6. 3M Transdermal and Transmucosal Drug Delivery Major Business
Table 7. 3M Transdermal and Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 8. 3M SWOT Analysis
Table 9. 3M Transdermal and Transmucosal Drug Delivery Product and Solutions
Table 10. 3M Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Tesa Labtec Corporate Information, Location and Competitors
Table 12. Tesa Labtec Transdermal and Transmucosal Drug Delivery Major Business
Table 13. Tesa Labtec Transdermal and Transmucosal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 14. Tesa Labtec SWOT Analysis
Table 15. Tesa Labtec Transdermal and Transmucosal Drug Delivery Product and Solutions
Table 16. Tesa Labtec Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Corium International Corporate Information, Location and Competitors
Table 18. Corium International Transdermal and Transmucosal Drug Delivery Major Business
Table 19. Corium International Transdermal and Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 20. Corium International SWOT Analysis
Table 21. Corium International Transdermal and Transmucosal Drug Delivery Product and Solutions
Table 22. Corium International Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Antares Pharma Corporate Information, Location and Competitors
Table 24. Antares Pharma Transdermal and Transmucosal Drug Delivery Major Business
Table 25. Antares Pharma Transdermal and Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 26. Antares Pharma SWOT Analysis
Table 27. Antares Pharma Transdermal and Transmucosal Drug Delivery Product and Solutions
Table 28. Antares Pharma Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Tapemark Corporate Information, Location and Competitors
Table 30. Tapemark Transdermal and Transmucosal Drug Delivery Major Business
Table 31. Tapemark Transdermal and Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 32. Tapemark SWOT Analysis
Table 33. Tapemark Transdermal and Transmucosal Drug Delivery Product and Solutions
Table 34. Tapemark Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Aveva Drug Delivery Systems Corporate Information, Location and Competitors
Table 36. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Major Business
Table 37. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 38. Aveva Drug Delivery Systems SWOT Analysis
Table 39. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Product and Solutions
Table 40. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Pantec Biosolutions Corporate Information, Location and Competitors
Table 42. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Major Business
Table 43. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 44. Pantec Biosolutions SWOT Analysis
Table 45. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Product and Solutions
Table 46. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. DURECT Corporate Information, Location and Competitors
Table 48. DURECT Transdermal and Transmucosal Drug Delivery Major Business
Table 49. DURECT Transdermal and Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 50. DURECT SWOT Analysis
Table 51. DURECT Transdermal and Transmucosal Drug Delivery Product and Solutions
Table 52. DURECT Transdermal and Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Transdermal and Transmucosal Drug Delivery Revenue (Million USD) by Players (2015-2020)
Table 54. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Players (2015-2020)
Table 55. Global Transdermal and Transmucosal Drug Delivery Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Regions (2015-2020)
Table 57. North America Transdermal and Transmucosal Drug Delivery Revenue by Countries (2015-2020)
Table 58. North America Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 59. Europe Transdermal and Transmucosal Drug Delivery Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Transdermal and Transmucosal Drug Delivery Revenue by Countries (2015-2020)
Table 62. South America Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Transdermal and Transmucosal Drug Delivery Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 65. Global Transdermal and Transmucosal Drug Delivery Revenue (Million USD) by Type (2015-2020)
Table 66. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Type (2015-2020)
Table 67. Global Transdermal and Transmucosal Drug Delivery Revenue Forecast by Type (2021-2025)
Table 68. Global Transdermal and Transmucosal Drug Delivery Revenue by Application (2015-2020)
Table 69. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Application (2015-2020)
Table 70. Global Transdermal and Transmucosal Drug Delivery Revenue Forecast by Application (2021-2025)
Table 71. Global Transdermal and Transmucosal Drug Delivery Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Transdermal and Transmucosal Drug Delivery Picture
Figure 2. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Type in 2019
Figure 3. Transdermal Drug Delivery Picture
Figure 4. Transmucosal Drug Delivery Picture
Figure 5. Transdermal and Transmucosal Drug Delivery Revenue Market Share by Application in 2019
Figure 6. Clinics Picture
Figure 7. Hospitals Picture
Figure 8. Others Picture
Figure 9. Global Transdermal and Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Transdermal and Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Transdermal and Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Transdermal and Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Transdermal and Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Transdermal and Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Transdermal and Transmucosal Drug Delivery Revenue Market Share in 2019
Figure 18. Global Top 10 Players Transdermal and Transmucosal Drug Delivery Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Transdermal and Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Regions (2015-2020)
Figure 22. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Regions in 2018
Figure 23. North America Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 24. Europe Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 26. South America Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 28. North America Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 29. North America Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries in 2019
Figure 30. USA Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 31. Canada Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 33. Europe Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries in 2019
Figure 35. Germany Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 36. UK Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 37. France Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 38. Russia Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 39. Italy Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries in 2019
Figure 42. China Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 43. Japan Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 44. Korea Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 45. India Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 47. South America Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 48. South America Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries in 2019
Figure 49. Brazil Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Transdermal and Transmucosal Drug Delivery Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 54. UAE Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Transdermal and Transmucosal Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 57. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Type (2015-2020)
Figure 58. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Type in 2019
Figure 59. Global Transdermal and Transmucosal Drug Delivery Market Share Forecast by Type (2021-2025)
Figure 60. Global Transdermal Drug Delivery Revenue Growth Rate (2015-2020)
Figure 61. Global Transmucosal Drug Delivery Revenue Growth Rate (2015-2020)
Figure 62. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Application (2015-2020)
Figure 63. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Application in 2019
Figure 64. Global Transdermal and Transmucosal Drug Delivery Market Share Forecast by Application (2021-2025)
Figure 65. Global Clinics Revenue Growth Rate (2015-2020)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Transdermal and Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Transdermal and Transmucosal Drug Delivery Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Transdermal and Transmucosal Drug Delivery Revenue Market Forecast (2021-2025)
Figure 72. Europe Transdermal and Transmucosal Drug Delivery Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Transdermal and Transmucosal Drug Delivery Revenue Market Forecast (2021-2025)
Figure 74. South America Transdermal and Transmucosal Drug Delivery Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Transdermal and Transmucosal Drug Delivery Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---